CRO News

HungaroTrial contributed to EU authorization of a new COVID-19 medication, Regkirona (CT-P59)

Published on 22 November 2021

HungaroTrial contributed to EU authorization of a new COVID-19 medication.

HungaroTrial is proud to announce the completion of enrolment in a global Phase III. Breast Cancer trial

Published on 29 April 2021

HungaroTrial is proud to announce the completion of enrolment in a global Breast Cancer trial

HungaroTrial is featured in a recent article in the leading news media in South Korea

Published on 20 April 2021

HungaroTrial is featured in a recent article in the leading news media in South Korea

We are announcing the launch of our new video about HungaroTrial’s Medical Device Services

Published on 08 September 2020

We are announcing the launch of our new video about HungaroTrial’s Medical Device Services

HungaroTrial has received approval for a new COVID-19 phase II. clinical trial in Romania

Published on 24 August 2020

HungaroTrial has received approval for a new COVID19 phase II. clinical trial in Romania

HungaroTrial CRO has been selected for the full service coverage of a Phase I. vaccination clinical trial

Published on 12 February 2020

HungaroTrial CRO has been selected for the full service coverage of a Phase I. vaccination clinical trial

Proud to Announce: We are ISO 9001 Certified

Published on 16 September 2019

We at HungaroTrial are proud to announce successful integration into a quality management system according to ISO 9001:2015.

Read more: Proud to Announce: We are ISO 9001 Certified

We are announcing the launch of our new Medical Device website

Published on 17 April 2019

After months of hard work and dedication, we are pleased to announce the launch of our brand new Medical Device Website!

HungaroTrial is happy to announce their collaboration in the Largest Single Phase III Breast Cancer Clinical Trial in its History

Published on 16 November 2018

HungaroTrial was selected to manage sites in the CEE region in a randomized, phase III study which will include more than 4,000 patients from around the world.

CEO of HungaroTrial CRO has received Scientist of Medicines Development postgraduate certification at Semmelweis University

Published on 12 February 2018

Dr. Lajos Sárosi, CEO of HungaroTrial CRO has received his postgraduate degree at Semmelweis University

Announcing the opening of our new office in Prague, Czech Republic

Published on 28 September 2017

HungaroTrial, a privately held Contract Research Organization is delighted to announce the opening of its new wholly-owned subsidiary office in Prague.

We are happy to announce the successful accomplishment of a device study in acute myocardial infarct

Published on 05 July 2017

This year HungaroTrial successfully completed a medical device study in patients with acute myocardial infarction for a US-based Sponsor.

Announce of opening HT Research UK

Published on 20 January 2017

We are happy to announce the opening of HT Research UK in the heart of the City of London, England

Read more: Announce of opening HT Research UK

We are happy to announce the successful accomplishment of a Phase2 Infectology study

Published on 29 December 2016

In December 2016, HungaroTrial successfully completed a Phase II Infectology study in the CEE region for a US-based Sponsor.

Winning Excellence Award from the Cra Academija in Serbia

Published on 12 January 2016

HungaroTrial is proud to announce that our Serbian Country Manager won Excellence Award from the Cra Academija in Serbia.

Read more: Winning Excellence Award from the Cra Academija in Serbia

Announce of opening new office in Sofia , Bulgaria

Published on 16 November 2015

HungaroTrial a privately held Contract Research Organization announces that it has opened a new wholly-owned subsidiary office in Sofia, Bulgaria.

Read more: Announce of opening new office in Sofia , Bulgaria

HungaroTrial opens up new office in Belgrade, Serbia

Published on 12 January 2015

HungaroTrial is proud to announce the opening of an additional office in Belgrade, Serbia

Read more: HungaroTrial opens up new office in Belgrade, Serbia

HungaroTrial has been selected as the full service provider for a PhaseII. multicenter, multinational clinical trial

Published on 08 September 2014

HungaroTrial has been selected as the full service provider for a Phase II. multicenter, multinational clinical trial

We are happy to announce that we have successfully concluded a Phase III Anal Fissure study

Published on 27 May 2014

We are happy to announce that we have successfully concluded a Phase III Anal Fissure study

HungaroTrial Featured in Recent Interview on CEbiotech.com

Published on 08 March 2013

HungaroTrial Featured in Recent Interview on CEbiotech.com

Read more: HungaroTrial Featured in Recent Interview on CEbiotech.com

HungaroTrial launches informative four-part Clinical Trials Webinar Series addressing Eastern Europe

Published on 07 May 2012

HungaroTrial launches informative four-part Clinical Trials Webinar Series addressing Eastern Europe

HungaroTrial extends its reach to two additional countries

Published on 09 April 2012

HungaroTrial extends its reach to two additional countries

Read more: HungaroTrial extends its reach to two additional countries

HungaroTrial.com – market-leading CRO unveils brand new image

Published on 10 January 2012

HungaroTrial.com – market-leading CRO unveils brand new image

Come friend us on Facebook

Published on 03 January 2012

Come friend us on Facebook!

Follow HungaroTrial on Twitter!